VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 34 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,179,171 | -39.6% | 1,380,650 | -6.3% | 0.01% | -35.3% |
| Q2 2023 | $35,049,522 | +224260.0% | 1,473,288 | +139.9% | 0.02% | +88.9% |
| Q1 2023 | $15,622 | -39.0% | 614,089 | -29.9% | 0.01% | -35.7% |
| Q4 2022 | $25,596 | -99.8% | 876,254 | +15.0% | 0.01% | +55.6% |
| Q3 2022 | $15,630,000 | +20.0% | 762,060 | -32.3% | 0.01% | +12.5% |
| Q2 2022 | $13,029,000 | -27.8% | 1,126,085 | +15.4% | 0.01% | -20.0% |
| Q1 2022 | $18,039,000 | +97.3% | 975,618 | +111.0% | 0.01% | +100.0% |
| Q4 2021 | $9,141,000 | +244.4% | 462,390 | +186.6% | 0.01% | +150.0% |
| Q3 2021 | $2,654,000 | +23.3% | 161,345 | +37.1% | 0.00% | +100.0% |
| Q2 2021 | $2,153,000 | +198.6% | 117,715 | +172.6% | 0.00% | 0.0% |
| Q1 2021 | $721,000 | – | 43,176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 680,768 | $11,376,000 | 2.18% |
| COMMODORE CAPITAL LP | 185,781 | $3,104,000 | 1.24% |
| Ghost Tree Capital, LLC | 300,000 | $5,013,000 | 1.18% |
| Logos Global Management LP | 550,000 | $9,191,000 | 0.90% |
| Atlas Venture Advisors, Inc. | 209,505 | $3,501,000 | 0.65% |
| BVF INC/IL | 463,504 | $7,745,000 | 0.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 27,586 | $461,000 | 0.25% |
| Fairmount Funds Management LLC | 35,092 | $581,000 | 0.24% |
| Soleus Capital Management, L.P. | 67,685 | $1,131,000 | 0.20% |
| Cormorant Asset Management, LP | 459,144 | $7,672,000 | 0.17% |